Bank of Stockton’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EPGL
RG
SAM
CDDEC
MGP
Bank of Stockton's AZN Position: Q2 2026 in Review
Bank of Stockton increased its AstraZeneca (AZN) stake by 1.7% in Q2 2026, buying an estimated $12.4K and bringing the position to 4,006 shares worth $760K. The position accounts for 0.21% of the portfolio, ranked #75.
Bank of Stockton first reported a position in AZN in Q2 2024 and has held it in 9 quarters since. The position peaked at $833K in Q4 2025. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Bank of Stockton held 4,006 shares of AstraZeneca worth $760K as of Q2 2026.
- Bank of Stockton bought 66 AstraZeneca shares in Q2 2026, an estimated $12.4K.
- AstraZeneca made up 0.21% of Bank of Stockton's portfolio in Q2 2026, its #75 holding.
- Bank of Stockton first reported a position in AstraZeneca in Q2 2024 and has held it in 9 quarters since.
- Bank of Stockton's AstraZeneca position peaked at $833K in Q4 2025.
- 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Bank of Stockton's 13F filing for Q2 2026, filed 29 Jul 2026.